Martin Shkreli discusses why large tech incumbents failed to launch consumer-facing generative AI products before OpenAI.
Assertion Contradicted
Shkreli: Zero percent of patients lost access to Daraprim after price hike
“Zero percent.”
Insight
Shkreli: Drug prices should equal the averted cost of alternative care
“When you do the pricing, I think that the best logical thing to do is pick a price that the alternative care, in other words, a world without this drug, you would forego all those costs for this drug.”
Prediction Not checkable as stated
Shkreli: Machines will replace human doctors entirely within 30 years
“There's, if we do our jobs right, there's no such thing as a doctor in 30 years. That every operation, every prescription, every piece of medical advice you ever get from now on comes from a machine and it costs 10 cents.”
Assertion Not checkable as stated
Shkreli: Made his wealth in clinical drug development, not price hikes
“A lot of people think that I take medicines and raise prices. Well, this drug was barely in human beings. It had been in like 30 or 50 people. Helped up until that point. And, you know, I made most of my money in, in sort of developments in, in environment on …”
Opinion
Shkreli: Big Law Firms Easily Secure Rapid Federal Indictments
“And it's not hard if you go to a law firm, you know, like a Cooley, Cleary, Gottlieb, Skadden, Arbs, pick your, Paul Weiss, pick your biggest law firm. You say, hey, we have this guy, he did something bad, you know, look into this. You know, usually you'll get…”
Assertion Contradicted
Shkreli: Every insurer covered Daraprim because it was cheaper than ICU stays
“There's not an insurer in the world that didn't cover Daraprim because If you don't pay the 50,000 dollars roughly what Daraprim costs for a whole course, forget per pill, about 50 grand if you end up needing Daraprim. If you don't pay that, you're gonna pay f…”